InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,948.30
(
1.06%
)
Post# of 20775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

qotsa55

Send PM Follow Ignore
Followers 5
Posts 435
Boards Moderated 0
Alias Born 04/05/2012

qotsa55

Re: None

Friday, 10/18/2013 6:07:17 PM

Friday, October 18, 2013 6:07:17 PM

Post# of 20775
With the exception of OX1 that Intellect licensed to Viopharma, does anyone here know if the research with any of Intellects other antibodies are still going on? RV03, CONJAMAB-A, or has everything been halted?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up